What is cytokinetics a company? Company. Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and best-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining.What did cytokinetics announce on august 31? SOUTH SAN FRANCISCO, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on August 31, 2021 it granted stock options to purchase an aggregate of 113,600 shares of common stock to 10 new employees, whose employment commenced in August 2021, as a material inducement to their employment.What is cytokinetics ck 3773274 drug? Cytokinetics is developing CK-3773274 (CK-274), an oral, small-molecule myosin inhibitor, to treat hypertrophic cardiomyopathy (HCM). The drug’s Phase 1 trial, which assessed the safety and tolerability of single and multiple oral doses, started in December 2018. In September 2019, the company released the results of the study.Is cytokinetics cytk a strong sell on the zacks rank list? CYTK, GEVO, ISEE, MCFE, and NOMD have been added to the Zacks Rank #5 (Strong Sell) List on August 18, 2021. CYTK earnings call for the period ending June 30, 2021. Cytokinetics (CYTK) delivered earnings and revenue surprises of -32.31% and -49.97%, respectively, for the quarter ended June 2021.
Cytokinetics 9,062 followers on LinkedIn. Empowering Muscle Empowering Lives Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first
Phone Number 6506243010 Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. Lists Featuring This Company